[Pyr-11]-beta-Amyloid (11-42) is an N-terminally cyclized amyloid-β fragment in which residue 11 forms pyroglutamate, markedly affecting aggregation behavior. The modification enhances hydrophobic character and can accelerate fibril formation in model systems. Its sequence provides a tool for studying truncated amyloid species. Researchers use it to examine mechanisms governing peptide misfolding and oligomerization.
CAT No: A13206
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More